Dexamethasone-induced skeletal muscle atrophy was associated with upregulation of myostatin promoter activity

Research in Veterinary Science

Volumn 94, Issue 1, 2013, Pages 84-89

  Qin, Jian ^a   Du, Rong ^a   Yang, Ya Qun ^a   Zhang, Hong Qiang ^a   Li, Qing ^b   Liu, Lin ^b   Guan, Hong ^b   Hou, Jian ^b   An, Xiao Rong ^b  

^a SHANXI AGRICULTURAL UNIVERSITY   (China)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Dexamethasone; Myostatin promoter; Skeletal muscle atrophy; Ultrastructure

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; MYOSTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CACHEXIA; CELL ULTRASTRUCTURE; CONTROLLED STUDY; GENE EXPRESSION; MITOCHONDRION; MOUSE; MUSCLE ATROPHY; MUSCLE LENGTH; NONHUMAN; PROMOTER REGION; PROTEIN MOTIF; RECEPTOR BINDING; SARCOMERE; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE; UPREGULATION;

ANIMALS; DEXAMETHASONE; FEMALE; GENE EXPRESSION; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MIFEPRISTONE; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOSTATIN; PROMOTER REGIONS, GENETIC; UP-REGULATION;

MUS;

EID: 84871511163     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2012.07.018     Document Type: Article

References (27)

1. Allen D.L., Loh A.S. Post-transcriptional mechanisms involving MicroRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle. American Journal of Physiology. Cell Physiology 2011, 300:C124-137.
2. Amthor H., Macharia R., Navarrete R., Schuelke M., Brown S.C., Otto A., Voit T., Muntoni F., Vrbóva G., Partridge T., Zammit P., Bunger L., Patel K. Lack of myostatin results in excessive muscle growth but impaired force generation. PNAS 2007, 104:1835-1840.
3. Davis H.L., Whalen R.G., Demeneix B.A. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Human Gene Therapy 1993, 4:151-159.
4. Du R., An X.R., Chen Y.F., Qin J. Some motifs were important for myostatin transcriptional regulation in sheep. Journal of Biochemistry and Molecular Biology 2007, 40:547-553.
5. Funkenstein B., Balas V., Rebhan Y., Pliatner A. Characterization and functional analysis of the 5' flanking region of Sparus aurata myostatin-1 gene. Comparative Biochemistry and Physiology. Part A, Molecular and Integrative Physiology 2009, 153:55-62.
6. Gilson H., Schakman O., Combaret L., Lause P., Grobet L., Attaix D., Ketelslegers J.M., Thissen J.P. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy. Endocrinology 2007, 148:452-460.
7. Grade C.V.C., Salerno M.S., Schubert F.R., Dietrich S., Alvares L.E. An evolutionarily conserved myostatin proximal promoter/enhancer confers basal levels of transcription and spatial specificity in vivo. Development Genes and Evolution 2009, 219:497-508.
8. Grobet L., Martin L.J.R., Poncelet D., Pirottin D., Brouwers B., Riquet J., Schoeberlein A., Dunner S., Ménissier F., Massabanda J., Fries R., Hanset R., Georges M. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nature Genetics 1997, 17:71-74.
9. Holley A.K., St Clair D.K. Watching the watcher: regulation of p53 by mitochondria. Future Oncology 2009, 5:117-130.
10. Lang C.H., Silvis C., Nystrom G., Frost R.A. Regulation of myostatin by glucocorticoids after thermal injury. The FASEB Journal 2001, 15:NIL323-NIL338.
11. Ma K., Mallidis C., Artaza J., Taylor W., Gonzalez-Cadavid N., Bhasin S. Characterization of 5'-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. American Journal of Physiology. Endocrinology and Metabolism 2001, 281:E1128-E1136.
12. Ma K., Mallidis C., Bhasin S., Mahabadi V., Artaza J., Gonzalez-Cadavid N., Arias J., Salehian B. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. American Journal of Physiology. Endocrinology and Metabolism 2003, 285:E363-E371.
13. Marone J.R., Falduto M.T., Essig D.A., Hickson R.C. Effects of glucocorticoids and endurance training on cytochrome oxidase expression in skeletal muscle. Journal of Applied Physiology 1994, 77:1685-1690.
14. McPherron A.C., Lee S.J. Double muscling in cattle due to mutations in the myostatin gene. PNAS 1997, 94:12457-12461.
15. McPherron A.C., Lawler A.M., Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 1997, 387:83-90.
16. Millay D.P., Sargent M.A., Osinska H., Baines C.P., Barton E.R., Vuagniaux G., Sweeney H.L., Robbins J., Molkentin J.D. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nature Medicine 2008, 14:442-447.
17. Mitsui T., Azuma H., Nagasawa M., Iuchi T., Akaike M., Odomi M., Matsumoto T. Chronic corticosteroid administration causes mitochondrial dysfunction in skeletal muscle. Journal of Neurology 2002, 249:1004-1009.
18. Rios R., Fernandez-Nocelos S., Carneiro I., Arce V.M., Devesa J. Differential response to exogenous and endogenous myostatin in myoblasts suggests myostatin acts as an autocrine factor in vivo. Endocrinology 2004, 145:2795-2803.
19. Salerno M.S., Thomas M., Forbes D., Watson T., Kambadur R., Sharma M. Molecular analysis of fiber type-specific expression of murine myostatin promoter. American Journal of Physiology. Cell Physiology 2004, 287:C1031-1040.
20. Schakman O., Gilson H., Thissen J.P. Mechanisms of glucocorticoid-induced myopathy. Journal of Endocrinology 2008, 197:1-10.
21. Schakman O., Kalista S., Bertrand L., Lause P., Verniers J., Ketelslegers J.M., Thissen J.P. Role of Akt/GSK-3β/β-catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor-I in glucocorticoid-treated Rats. Endocrinology 2008, 149:3900-3908.
22. Schuelke M., Wagner K.R., Stolz L.E., Hübner C., Riebel T., Kömen W., Braun T., Tobin J.F., Lee S.J. Myostatin mutation associated with gross muscle hypertrophy in a child. The New England Journal of Medicine 2004, 350:2682-2688.
23. Sundaresan N.R., Saxena V.K., Singh R., Jain P., Singh K.P., Anish D., Singh N., Saxena M., Ahmed K.A. Expression profile of myostatin mRNA during the embryonic organogenesis of domestic chicken (Gallus gallus domesticus). Research in Veterinary Science 2008, 85:86-91.
24. Thomas M., Langley B., Berry C., Sharma M., Kirk S., Bass J., Kambadur R. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. The Journal of Biological Chemistry 2000, 275:40235-40243.
25. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science 1990, 247:1465-1468.
26. Zheng B., Ohkawa S., Li H., Roberts-Wilson T.K., Russ Price S. FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/MAFbx expression during glucocorticoid-induced skeletal muscle atrophy. The FASEB Journal 2010, 24:2660-2669.
27. Zimmers T.A., Davies M.V., Koniaris L.G., Haynes P., Esquela A.F., Tomkinson K.N., McPherron A.C., Wolfman N.M., Lee S.J. Induction of cachexia in mice by systemically administered myostatin. Science 2002, 296:1486-1488.